Trends in prescribing proton pump inhibitors in Taiwan: 1997 - 2000.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  International journal of clinical pharmacology and therapeutics

• Publication date

  2003-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.5414/CPP41207PMID 12776811
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The clinical and economic impact of competing management strategies for gastro‐oesophageal reflux disease

  2002cited by this paper
• Primary resistance to antibiotics and its clinical impact on the efficacy of Helicobacter pylori lansoprazole‐based triple therapies

  2002cited by this paper
• Proton pump inhibitors: a study of GPs' prescribing.

  2001cited by this paper
• Economic considerations in the treatment of gastroesophageal reflux disease: a review

  2000cited by this paper
• A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease

  2000cited by this paper
• Strategies for reducing the prescribing of proton pump inhibitors (PPIs): patient self-regulation of treatment may be an under-exploited resource.

  2000cited by this paper
• Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease

  1999cited by this paper
• Can restrictions on reimbursement for anti-ulcer drugs decrease Medicaid pharmacy costs without increasing hospitalizations?

  1999cited by this paper
• Compliance with restrictions on the subsidized use of proton pump inhibitors in Australia.

  1998cited by this paper
• Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database

  1998cited by this paper
• Guidelines for the management of Helicobacter pylori infection

  1998cited by this paper
• Proton-pump inhibitors: three of a kind?

  1997cited by this paper
• Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology.

  1996cited by this paper
• Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication.

  1996cited by this paper

• Asymptomatic enteric pathogen carriage and its association with proton pump inhibitors use in men who have sex with men in Taiwan, 2019-2022.

  2024cites this paper
• National trends in prescription proton pump inhibitor use and expenditure in the United States in 2002-2017.

  2020cites this paper
• Proton pump inhibitors use and risk of chronic kidney disease in diabetic patients.

  2019cites this paper
• Studies of Drug Utilization

  2019cites this paper
• Correlation of Proton Pump Inhibitors with Pulmonary Tuberculosis: A Case-Control Study in Taiwan

  2017cites this paper
• Overuse of Acid-Suppression Therapy at an Urban Tertiary Hospital

  2015cites this paper
• Acid suppressive agents and risk of Mycobacterium Tuberculosis: case–control study

  2014cites this paper
• Proton Pump Inhibitor Use in the U.S. Ambulatory Setting, 2002–2009

  2013cites this paper
• Inappropriate Prescribing of Proton Pump Inhibitors in Older Patients

  2012cites this paper
• Inappropriate prescribing of proton pump inhibitors in older patients: effects of an educational strategy.

  2012cites this paper
• S1056 Medical Management of Inflammatory Bowel Disease; Patterns of Infliximab Use Amongst Canadian Gastroenterologists

  2008cites this paper
• Long-term management of GERD in the elderly with pantoprazole

  2007cites this paper
• Review article: the long‐term use of proton‐pump inhibitors

  2005cites this paper
• Estimating medical costs of gastroenterological diseases.

  2004cites this paper
• Current awareness: Pharmacoepidemiology and drug safety

  2003cites this paper
• Pharmacoepidemiology and drug safety

  2003cites this paper
• Patterns and costs of antipsychotic drug use in Taiwan: 1997 to 2001

  2003cites this paper